The long-term trajectory of the Intraocular Melanoma Treatment Market is highly dependent on the successful completion of late-stage clinical trials evaluating next-generation targeted molecular therapies and light-activated drug configurations. These upcoming medical innovations aim to selectively destroy malignant ocular cells while leaving healthy surrounding photoreceptors completely...